The American Heart Association Scientific Statement sheds light on treatment approaches for pediatric cardiomyopathy. From stage-based interventions to novel therapies and collaborative networks, this article explores the advancements in managing this complex condition.
Read MoreA study highlights the significance of cardiac magnetic resonance imaging (CMR) in patients with ventricular arrhythmias. Find out how CMR aids in diagnosis, alters treatment strategies, and predicts major adverse cardiac events, providing crucial insights for improved patient care.
Read MoreBristol Myers Squibb’s mavacamten receives FDA approval for updated labeling, showcasing its efficacy in reducing the need for septal reduction therapy in patients with obstructive hypertrophic cardiomyopathy based on positive data from the VALOR-HCM trial.
Read More
A recent scientific statement from the American Heart Association highlights the detrimental impact of toxic metals, including lead, cadmium, and arsenic, on cardiovascular health.
Read More
A new study presented at the American Thoracic Society International Conference highlights the increased risk of acute cardiovascular events in patients with acute COPD exacerbations.
Read More